Randolph CO Inc Merck & Co., Inc. Transaction History

Randolph CO Inc

$895 Million
Q4 2024

A detailed history of Randolph CO Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Randolph CO Inc holds 206,070 shares of MRK stock, worth $19.2 Million. This represents 2.29% of its overall portfolio holdings.

Number of Shares

206,070

Previous 205,021 0.51%

Holding current value

$19.2 Million

Previous $23.3 Million 11.95%

% of portfolio

2.29%

Previous 2.71%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$96.31 - $114.76 $101,029 - $120,383	1,049 Added 0.51%	206,070 $20.5 Million
Q3 2024 Oct 16, 2024	SELL	$111.15 - $128.97 $14,671 - $17,024	-132 Reduced 0.06%	205,021 $23.3 Million
Q2 2024 Jul 22, 2024	BUY	$123.8 - $132.96 $5,818 - $6,249	47 Added 0.02%	205,153 $25.4 Million
Q1 2024 Apr 24, 2024	BUY	$113.24 - $131.95 $22.9 Million - $26.7 Million	202,278 Added 7152.69%	205,106 $27.1 Million
Q4 2023 Jan 26, 2024	BUY	$100.18 - $109.02 $10,218 - $11,120	102 Added 3.74%	2,828 $308,000
Q2 2021 Aug 11, 2021	SELL	$70.31 - $77.77 $16.2 Million - $17.9 Million	-229,866 Reduced 98.83%	2,726 $212,000
Q1 2021 Apr 12, 2021	BUY	$68.86 - $81.11 $4,957 - $5,839	72 Added 0.03%	232,592 $17.9 Million
Q4 2020 Jan 22, 2021	BUY	$71.77 - $79.65 $36,459 - $40,462	508 Added 0.22%	232,520 $19 Million
Q3 2020 Oct 27, 2020	SELL	$73.18 - $82.95 $3,293 - $3,732	-45 Reduced 0.02%	232,012 $19.2 Million
Q1 2020 Apr 23, 2020	BUY	$63.36 - $87.82 $14.7 Million - $20.4 Million	232,057 New	232,057 $17.9 Million
Q4 2017 Jan 30, 2018	SELL	$51.62 - $61.64 $727,377 - $868,569	-14,091 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$58.67 - $63.13 $826,718 - $889,564	14,091	14,091 $902,000

Others Institutions Holding MRK

# of Institutions

3,963

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $236B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Randolph CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Randolph CO Inc with notifications on news.

Account